Medtronic and Johnson & Johnson-backed healthcare company GI Dynamics has raised at least $76m venture funding in its seven year history.
US-based diabetes and obesity treatment company GI Dynamics, backed by the corporate venturing units of US-based healthcare companies Johnson & Johnson and Medtronic, has filed to float in Australia.
The company is looking to raise between A$85m ($88m) and A$102m, according to a filing with Australian regulator Australian Securities and Investment Commission.
The two corporations are investors in the company alongside venture capital firms Advanced Technology Ventures, Angel Healthcare Investors, Catalyst Health Ventures, Cutlass Capital, Domain Associates and Polaris…
